search
Back to results

Evaluation of a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy

Primary Purpose

Pancreatic Fistula

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Pancreaticojejunostomy technique
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pancreatic Fistula focused on measuring Postoperative pancreatic fistula, Pancreatic texture, Pancreatic duct diameter, Pancreatic consistency, Pancreaticoduodenectomy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients scheduled for elective pancreaticoduodenectomy
  • Pancreatic gland with high risk criteria for associated postoperative morbidity

Exclusion Criteria:

  • Patients do not accept participation
  • Pancreatic gland with intermediate or low risk criteria for associated postoperative morbidity

Sites / Locations

  • Department of Upper Abdominal Surgery, Linköping University Hospital
  • Department of Surgical gastroenterology, Karolinska University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Conventional anastomosis

Novel anastomosis

Arm Description

Conventional anastomosis: The pancreaticojejunostomy is carried out in a traditional way according to "Cattell's duct-to-mucosa technique".

Novel anastomosis: This the active comparator to the conventional anastomosis. A new pancreaticojejunostomy technique is used for the reconstruction. The pancreas is intubated into the jejunum.

Outcomes

Primary Outcome Measures

Clinically Relevant Postoperative Pancreatic Fistula
Postoperative pancreatic fistula as defined by the International Study Group of Pancreatic Fistula

Secondary Outcome Measures

Associated postoperative morbidity
Postoperative pancreatic fistula and abscesses or fluid collections adjacent to the pancreaticojejunostomy constitute a morbidity event; pancreaticojejunostomy-associated morbidity.

Full Information

First Posted
September 25, 2012
Last Updated
December 19, 2017
Sponsor
Karolinska Institutet
Collaborators
University Hospital, Linkoeping
search

1. Study Identification

Unique Protocol Identification Number
NCT01696903
Brief Title
Evaluation of a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy
Official Title
Clinical Randomized Trial Investigating a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy in Patients With a High Risk for Postoperative Pancreatic Fistula
Study Type
Interventional

2. Study Status

Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
November 2015 (Actual)
Study Completion Date
November 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
Collaborators
University Hospital, Linkoeping

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Pancreaticoduodenectomy is a surgical procedure for removing cancer in the pancreas, the bile system or the duodenum that is associated with a high rate of complications. The study wants to investigate whether a new technique to reconstruct the joint between the pancreatic gland and the short bowel can reduce the rate of severe complications after this complex surgical procedure.
Detailed Description
Pancreaticoduodenectomy is a complex surgical procedure for radically resecting tumors in the pancreatic head, distal bile duct or duodenum. Postoperative pancreatic fistula is the main contributor of severe postoperative morbidity after pancreaticoduodenectomy. Characteristics of the pancreatic gland like soft pancreatic consistency and small pancreatic main duct predispose for the postoperative fistula development. In high risk patients, the risk of suffering from associated postoperative morbidity is 50 percent which is considered unacceptable high. The aim of the current trial is to investigate whether a new anastomosing technique for the pancreaticojejunostomy can reduce the incidence of associated postoperative morbidity in patients undergoing pancreaticoduodenectomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Fistula
Keywords
Postoperative pancreatic fistula, Pancreatic texture, Pancreatic duct diameter, Pancreatic consistency, Pancreaticoduodenectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
123 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Conventional anastomosis
Arm Type
No Intervention
Arm Description
Conventional anastomosis: The pancreaticojejunostomy is carried out in a traditional way according to "Cattell's duct-to-mucosa technique".
Arm Title
Novel anastomosis
Arm Type
Active Comparator
Arm Description
Novel anastomosis: This the active comparator to the conventional anastomosis. A new pancreaticojejunostomy technique is used for the reconstruction. The pancreas is intubated into the jejunum.
Intervention Type
Procedure
Intervention Name(s)
Pancreaticojejunostomy technique
Other Intervention Name(s)
Pancreaticojejunal anastomosis, Intubating pancreaticojejunostomy, Dunking pancreaticojejunostomy, pancreatojejunostomy
Intervention Description
The anastomosis between jejunum and remnant pancreas has a pivotal impact on the incidence of postoperative pancreatic fistula. by this novel technique the remnant pancreas is intubated into the jejunum without extensive manipulation.
Primary Outcome Measure Information:
Title
Clinically Relevant Postoperative Pancreatic Fistula
Description
Postoperative pancreatic fistula as defined by the International Study Group of Pancreatic Fistula
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Secondary Outcome Measure Information:
Title
Associated postoperative morbidity
Description
Postoperative pancreatic fistula and abscesses or fluid collections adjacent to the pancreaticojejunostomy constitute a morbidity event; pancreaticojejunostomy-associated morbidity.
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Other Pre-specified Outcome Measures:
Title
Severity of postoperative complications
Description
The severity of postoperative complications as classified by the classification system of postoperative complications adopted for pancreatic surgery.
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 2 weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients scheduled for elective pancreaticoduodenectomy Pancreatic gland with high risk criteria for associated postoperative morbidity Exclusion Criteria: Patients do not accept participation Pancreatic gland with intermediate or low risk criteria for associated postoperative morbidity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christoph Ansorge, MD, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ralf Segersvärd, MD, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Study Director
Facility Information:
Facility Name
Department of Upper Abdominal Surgery, Linköping University Hospital
City
Linköping
ZIP/Postal Code
58185
Country
Sweden
Facility Name
Department of Surgical gastroenterology, Karolinska University Hospital
City
Stockholm
ZIP/Postal Code
14186
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
16003309
Citation
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005 Jul;138(1):8-13. doi: 10.1016/j.surg.2005.05.001.
Results Reference
background
PubMed Identifier
22556164
Citation
Ansorge C, Strommer L, Andren-Sandberg A, Lundell L, Herrington MK, Segersvard R. Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg. 2012 Aug;99(8):1076-82. doi: 10.1002/bjs.8784. Epub 2012 May 4.
Results Reference
background
PubMed Identifier
21845376
Citation
Kennedy EP, Yeo CJ. Dunking pancreaticojejunostomy versus duct-to-mucosa anastomosis. J Hepatobiliary Pancreat Sci. 2011 Nov;18(6):769-74. doi: 10.1007/s00534-011-0429-y.
Results Reference
background
Links:
URL
http://ki.se
Description
Issuer organization
URL
http://www.karolinska.se
Description
Investigation site
URL
http://www.lio.se
Description
Investigation site

Learn more about this trial

Evaluation of a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy

We'll reach out to this number within 24 hrs